Search Result "KILLER/DR5"
TRAIL: A Sword for Killing Tumors
Journal: Current Medicinal Chemistry
Volume: 17 Issue: 2 Year: 2010 Page: 3309-3317
Author(s): S. Wang
The Acetyltransferase KAT5 Inhibitor NU 9056 Promotes Apoptosis and Inhibits JAK2/STAT3 Pathway in Extranodal NK/T Cell Lymphoma
Journal: Anti-Cancer Agents in Medicinal Chemistry
Volume: 22 Issue: 8 Year: 2022 Page: 1530-1540
Author(s): Yuanyuan Qin,Mengdi Liu,Jun Jiao,Dongyun Tu,Meng Zhang,Dongmei Yan,Xuguang Song,Cai Sun,Feng Zhu,Xiangmin Wang,Wei Sang
TRAIL Agonists on Clinical Trials for Cancer Therapy: The Promises and the Challenges
Journal: Reviews on Recent Clinical Trials
Volume: 4 Issue: 1 Year: 2009 Page: 34-41
Author(s): Anita C. Bellail, Ling Qi, Patrick Mulligan, Vaninder Chhabra, Chunhai Hao
Tumor Targeted Therapies: Strategies for Killing Cancer but not Normal Cells
Journal: Current Cancer Therapy Reviews
Volume: 10 Issue: 1 Year: 2014 Page: 53-61
Author(s): Shulin Wang
Targeting Trail Towards the Clinic
Journal: Current Drug Targets
Volume: 12 Issue: 1 Year: 2011 Page: 2079-2090
Author(s): Devalingam Mahalingam, Corina N.A.M. Oldenhuis, Eva Szegezdi, Francis J. Giles, Elisabeth G.E. de Vries, Steven de Jong, Steffan T. Nawrocki
The Long and Winding Road to Cancer Treatment: The Trail System
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 17 Year: 2014 Page: 2819-2833
Author(s): Carmen Palacios,Rosario Yerbes,Tania Sanchez-Perez,Rosa Martin-Perez,Ana Cano-Gonzalez,Abelardo Lopez-Rivas
TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation
Journal: Current Drug Targets
Volume: 16 Issue: 4 Year: 2015 Page: 393-408
Author(s): Yun Song,Peter Buchwald
APO2L/TRAIL: New Insights in the Treatment of Autoimmune Disorders
Journal: Recent Patents on Inflammation & Allergy Drug Discovery
Volume: 5 Issue: 3 Year: 2011 Page: 184-199
Author(s): Alberto Anel, Luis Martinez-Lostao
Death Receptor Ligands: New Strategies for Combined Treatment with Ionizing Radiation
Journal: Current Medicinal Chemistry - Anti-Cancer Agents
Volume: 3 Issue: 5 Year: 2003 Page: 334-342
Author(s): Patrizia Marini, Claus Belka
Immunomodulatory Properties of Thalidomide Analogs: Pomalidomide and Lenalidomide, Experimental and Therapeutic Applications
Journal: Recent Patents on Endocrine, Metabolic & Immune Drug Discovery
Volume: 5 Issue: 3 Year: 2011 Page: 192-196
Author(s): Pawel Bodera, Wanda Stankiewicz